Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator.
Herrero-Beaumont G, Ivorra JA, Del Carmen Trabado M, Blanco FJ, Benito P, Martín-Mola E, Paulino J, Marenco JL, Porto A, Laffon A, Araújo D, Figueroa M, Branco J. Herrero-Beaumont G, et al. Among authors: marenco jl. Arthritis Rheum. 2007 Feb;56(2):555-67. doi: 10.1002/art.22371. Arthritis Rheum. 2007. PMID: 17265490 Free article. Clinical Trial.
Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors.
Suarez-Gestal M, Calaza M, Dieguez-Gonzalez R, Perez-Pampin E, Pablos JL, Navarro F, Narvaez J, Marenco JL, Herrero-Beaumont G, Fernandez-Gutierrez B, Lamas JR, de la Serna AR, Ortiz AM, Carreño L, Cañete JD, Caliz R, Blanco FJ, Balsa A, Gomez-Reino JJ, Gonzalez A. Suarez-Gestal M, et al. Among authors: marenco jl. Arthritis Rheum. 2009 Sep;60(9):2558-64. doi: 10.1002/art.24748. Arthritis Rheum. 2009. PMID: 19714582 Free article.
Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappaB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility.
Dieguez-Gonzalez R, Calaza M, Perez-Pampin E, Balsa A, Blanco FJ, Cañete JD, Caliz R, Carreño L, de la Serna AR, Fernandez-Gutierrez B, Ortiz AM, Herrero-Beaumont G, Pablos JL, Narvaez J, Navarro F, Marenco JL, Gomez-Reino JJ, Gonzalez A. Dieguez-Gonzalez R, et al. Among authors: marenco jl. Arthritis Res Ther. 2009;11(2):R42. doi: 10.1186/ar2650. Epub 2009 Mar 17. Arthritis Res Ther. 2009. PMID: 19292917 Free PMC article.
Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis.
Dieguez-Gonzalez R, Calaza M, Perez-Pampin E, de la Serna AR, Fernandez-Gutierrez B, Castañeda S, Largo R, Joven B, Narvaez J, Navarro F, Marenco JL, Vicario JL, Blanco FJ, Fernandez-Lopez JC, Caliz R, Collado-Escobar MD, Carreño L, Lopez-Longo J, Cañete JD, Gomez-Reino JJ, Gonzalez A. Dieguez-Gonzalez R, et al. Among authors: marenco jl. Arthritis Rheum. 2008 May;58(5):1264-74. doi: 10.1002/art.23426. Arthritis Rheum. 2008. PMID: 18438842 Free article.
Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: case-control study.
Ferreiro-Iglesias A, Calaza M, Perez-Pampin E, Lopez Longo FJ, Marenco JL, Blanco FJ, Narvaez J, Navarro F, Cañete JD, de la Serna AR, Gonzalez-Alvaro I, Herrero-Beaumont G, Pablos JL, Balsa A, Fernandez-Gutierrez B, Caliz R, Gomez-Reino JJ, Gonzalez A. Ferreiro-Iglesias A, et al. Among authors: marenco jl. Arthritis Res Ther. 2014 Sep 27;16(5):436. doi: 10.1186/s13075-014-0436-x. Arthritis Res Ther. 2014. PMID: 25260880 Free PMC article.
Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.
Rúa-Figueroa Í, López-Longo J, Galindo-Izquierdo M, Calvo-Alén J, Del Campo V, Olivé-Marqués A, Pérez-Vicente S, Fernández-Nebro A, Andrés M, Erausquin C, Tomero E, Horcada L, Uriarte E, Freire M, Montilla C, Sánchez-Atrio A, Santos G, Boteanu A, Díez-Álvarez E, Narváez J, Martínez-Taboada V, Silva-Fernández L, Ruiz-Lucea E, Andreu JL, Hernández-Beriain JÁ, Gantes M, Hernández-Cruz B, Pérez-Venegas J, Pecondón-Español Á, Marras C, Ibáñez-Barceló M, Bonilla G, Torrente V, Castellví I, Alegre JJ, Calvet J, Marenco JL, Raya E, Vázquez T, Quevedo V, Muñoz-Fernández S, Rodríguez-Gómez M, Ibáñez J, Pego-Reigosa JM. Rúa-Figueroa Í, et al. Among authors: marenco jl. Semin Arthritis Rheum. 2017 Aug;47(1):38-45. doi: 10.1016/j.semarthrit.2017.01.010. Epub 2017 Jan 27. Semin Arthritis Rheum. 2017. PMID: 28259425 Free article.
Abatacept use in rheumatoid arthritis: evidence review and recommendations.
Martín Mola E, Balsa A, Martínez Taboada V, Sanmartí R, Marenco JL, Navarro Sarabia F, Gómez-Reino J, Alvaro-Gracia JM, Román Ivorra JA, Lojo L, Plasencia C, Carmona L; Spanish expert panel of rheumatologists. Martín Mola E, et al. Among authors: marenco jl. Reumatol Clin. 2013 Jan-Feb;9(1):5-17. doi: 10.1016/j.reuma.2012.05.001. Epub 2012 Jul 4. Reumatol Clin. 2013. PMID: 22766432 Free article. English, Spanish.
Long-term followup of patients receiving combined therapy with cyclosporine and methotrexate.
González-Gay MA, Blanco R, García-Porrúa C, Ibáñez D, Vázquez-Caruncho M, Sánchez-Bursón J, Marenco JL. González-Gay MA, et al. Among authors: marenco jl. Arthritis Rheum. 1998 Sep;41(9):1703-4. doi: 10.1002/1529-0131(199809)41:9<1703::AID-ART25>3.0.CO;2-D. Arthritis Rheum. 1998. PMID: 9751107 Clinical Trial. No abstract available.
Recommendations for the use of parenteral methotrexate in rheumatic diseases.
Tornero Molina J, Calvo Alen J, Ballina J, Belmonte MÁ, Blanco FJ, Caracuel MÁ, Carbonell J, Corominas H, Chamizo E, Hidalgo C, Ivorra JR, Marenco JL, Moreno Muelas JV, Muñoz-Fernández S, Nolla JM, Pérez T, Sanmarti R, Trenor P, Urrego C, Vidal J, Rosas Gomez de Salazar J. Tornero Molina J, et al. Among authors: marenco jl. Reumatol Clin (Engl Ed). 2018 May-Jun;14(3):142-149. doi: 10.1016/j.reuma.2016.12.001. Epub 2017 Jan 9. Reumatol Clin (Engl Ed). 2018. PMID: 28082032 Free article. English, Spanish.
Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs in rheumatoid arthritis: results of the GO-MORE study in Spain.
Alonso A, González CM, Ballina J, García Vivar ML, Gómez-Reino JJ, Marenco JL, Fernández-Nebro A, Ordás C, Cea-Calvo L, Arteaga MJ, Sanmartí R. Alonso A, et al. Among authors: marenco jl. Reumatol Clin. 2015 May-Jun;11(3):144-50. doi: 10.1016/j.reuma.2014.05.002. Epub 2014 Jul 10. Reumatol Clin. 2015. PMID: 25022442 Free article. Clinical Trial.
46 results